DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer.
Li Y, Liao L, Kong L, Jiang W, Tang J, Han K, Hou Z, Zhang C, Zhou C, Zhang L, Sui Q, Xiao B, Mei W, Xu Y, Yu J, Hong Z, Pan Z, Ding P.
Li Y, et al. Among authors: zhou c.
Clin Transl Oncol. 2023 Jan;25(1):218-225. doi: 10.1007/s12094-022-02930-8. Epub 2022 Sep 8.
Clin Transl Oncol. 2023.
PMID: 36076121